HR 3206 112th Congress House Health Advisory bodies Department of Health and Human Services Drug safety, medical device, and laboratory regulation Food and Drug Administration (FDA) Government ethics and transparency, public corruption Health technology, devices, supplies

Cultivating Scientific Expertise to Foster Innovation for Patients Act of 2011

Introduced: October 14, 2011 See on congress.gov

Everywhere this bill has been 3 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Oct 18, 2011

Referred to the Subcommittee on Health.

Oct 14, 2011

Introduced in House

Oct 14, 2011

Referred to the House Committee on Energy and Commerce.

Plain-English summary Congressional Research Service

Cultivating Scientific Expertise to Foster Innovation for Patients Act of 2011 - Amends the Federal Food, Drug, and Cosmetic Act to revise provisions related to financial interests of Food and Drug Administration (FDA) advisory committee members to require the Secretary of Health and Human Services (HHS) to ensure that individual appointments to advisory committees are made to promote scientific and technical expertise while at the same time minimizing any potential conflicts of interest. Requires the Secretary to consider, with respect to any financial interest constituting a potential conflict of interest, the type, nature, and magnitude of the financial interest. Declares that no specific factor shall be dispositive in the Secretary's evaluation of a particular financial interest.

Repeals the prohibition specifically applicable to FDA that prevents a member of an advisory committee from participating with respect to a particular matter if such individual or an immediate family member of such individual has a financial interest that could be affected by the advice given to the Secretary.

What's happening now October 18, 2011

Referred to the Subcommittee on Health.

Committees of jurisdiction 2